Similarly, in a model of human skin cancer and chronic myelogenous leukemia, it was shown that PARP1 positively regulates the activity of activator protein-1 and hypoxia inducible factor 1 alpha, thereby promoting tumor cell survival and tumor growth [19]. Here, HIF1A is linked to neoplasm.